Roche’s David Kallend on outcomes and post marketing data

  David Kallend, Global Clinical Leader and PD Group Medical Director at Roche is speaking at this years World Drug Safety Congress Europe on De-risking strategies for CV drug development including the use of novel imaging modalities to evaluate pre-clinical and clinical safety findings. We spent a few minutes asking his opinion on the safety data collection and the associated …